BIOT
Biotech Acquisition Co
$10.15
Earnings Summary
Revenue | $0Mn |
Net Profits | $1.26Mn |
Net Profit Margins | +Inf% |
Highlights
Biotech Acquisition Co’s revenue jumped NaN% since last year same period to $0Mn in the Q3 2022. On a quarterly growth basis, Biotech Acquisition Co has generated NaN% jump in its revenue since last 3-months.
Biotech Acquisition Co’s net profit fell -57.12% since last year same period to $1.26Mn in the Q3 2022. On a quarterly growth basis, Biotech Acquisition Co has generated -86.56% fall in its net profits since last 3-months.
Biotech Acquisition Co’s net profit margin jumped NaN% since last year same period to +Inf% in the Q3 2022. On a quarterly growth basis, Biotech Acquisition Co has generated NaN% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Biotech Acquisition Co post its latest quarter earnings
EPS Estimate Current Year | 0 |
Highlights
Biotech Acquisition Co’s earning per share (EPS) estimates for the current year stand at 0.
Key Ratios
Key ratios of the Biotech Acquisition Co post its Q3 2022 earnings
Earning Per Share (EPS) | 0.04 |
Highlights
Biotech Acquisition Co’s earning per share (EPS) fell -60% since last year same period to 0.04 in the Q3 2022. This indicates that the Biotech Acquisition Co has generated -60% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2022-11-22 | 0 | 0.04 | +Inf% |
₹0 US Stocks a/c Opening Fee